• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用脉压二氮嗪控制重度高血压。

Control of severe hypertension with pulse diazoxide.

作者信息

Wilson D J, Lewis R C, Vidt D G

出版信息

Cardiovasc Clin. 1981;12(2):79-91.

PMID:7344779
Abstract

Immediate or rapid reduction in blood pressure may be indicated in the management of hypertensive emergencies in patients with recognized cardiovascular or cerebrovascular disease. Our study has shown that pulse administration of diazoxide is effective in reducing blood pressure in these patients with severe, uncontrolled hypertension. Blood pressure reduction was gradual and could be titrated with repeated pulses of 50 or 75 mg of diazoxide. Pulse administration of diazoxide may represent the preferred method of administration in most patients when this potent antipressor agent is indicated. Our experience suggests that pulse diazoxide appears to be a suitable alternative to other parenteral antihypertensive agents and provides a gradual reduction of blood pressure in high-risk patients with severe, uncontrolled hypertension. The procedure carries a minimum risk of serious cardiovascular sequelae.

摘要

对于已确诊心血管或脑血管疾病的患者,在高血压急症的治疗中可能需要立即或快速降低血压。我们的研究表明,静脉推注二氮嗪对这些严重、血压控制不佳的患者有效降低血压。血压下降是渐进性的,可通过重复推注50或75毫克二氮嗪进行滴定。当需要使用这种强效抗高血压药物时,静脉推注二氮嗪可能是大多数患者的首选给药方法。我们的经验表明,静脉推注二氮嗪似乎是其他胃肠外抗高血压药物的合适替代方法,可使严重、血压控制不佳的高危患者血压逐渐降低。该操作发生严重心血管后遗症的风险极小。

相似文献

1
Control of severe hypertension with pulse diazoxide.用脉压二氮嗪控制重度高血压。
Cardiovasc Clin. 1981;12(2):79-91.
2
Diazoxide for hypertensive crisis.用于高血压危象的二氮嗪。
Am Fam Physician. 1975 May;11(5):128-30.
3
Acute treatment of hypertension with slow infusion of diazoxide.用二氮嗪缓慢输注进行高血压的急性治疗。
Arch Intern Med. 1983 May;143(5):882-4.
4
Diazoxide in the management of severe hypertension.
Acta Med Scand. 1975 Nov;198(5):358-8.
5
A new technique for safe and effective control of hypertension with intravenous diazoxide.一种使用静脉注射二氮嗪安全有效地控制高血压的新技术。
Curr Ther Res Clin Exp. 1976 Feb;19(2):185-8.
6
[Diazoxide in hypertensive crisis: rapid injection or slow infusion?].
Ned Tijdschr Geneeskd. 1981 Nov 7;125(45):1823-8.
7
A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial.肼屈嗪与小剂量推注二氮嗪治疗妊娠高血压急症的随机对照研究:PIVOT试验
Aust N Z J Obstet Gynaecol. 2007 Aug;47(4):279-85. doi: 10.1111/j.1479-828X.2007.00738.x.
8
[Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives].缬沙坦或缬沙坦/氢氯噻嗪治疗对血压、血压波动幅度及心率的影响。11447例高血压患者的开放观察研究结果
Dtsch Med Wochenschr. 2003 Mar 14;128(11):541-4. doi: 10.1055/s-2003-37855.
9
Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.尼日利亚一家三级医院高血压药物治疗的趋势变化:对新旧抗高血压药物的疗效、安全性、合理性和药物经济学的真实世界评估
J Hum Hypertens. 2003 Apr;17(4):277-85. doi: 10.1038/sj.jhh.1001538.
10
[Infusion of diazoxide in severe arterial hypertension].
Rev Clin Esp. 1982 Dec 15;167(5):305-8.

引用本文的文献

1
Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents.小儿高血压的药物治疗。对现有药物的疗效、安全性及剂量指南的全面综述。
Drugs. 1994 Dec;48(6):868-87. doi: 10.2165/00003495-199448060-00004.
2
Current management of hypertensive emergencies.高血压急症的当前管理。
Drugs. 1987 Aug;34(2):263-78. doi: 10.2165/00003495-198734020-00004.
3
Hypertensive emergencies and urgencies: definition, recognition, and management.高血压急症和亚急症:定义、识别与管理
J Gen Intern Med. 1988 Jan-Feb;3(1):64-74. doi: 10.1007/BF02595759.